In-Vitro Toxicology Testing Market is Forecasted to Surge USD 27,952.36 Million by 2030
Global In-Vitro Toxicology Testing Market research report has complete overview of the market covering various aspects such as product definition, segmentation based on various parameters, and the prevailing vendor landscape. The report lends a hand to stay up-to-date about the entire market and also puts forward holistic view of the market. With this market report, insights and realities of the HEALTHCARE industry can be focused which helps keep the business on the right track. A thorough analysis has been performed in this document to know the potential of the market in the present and the future prospects from various angles. Global In-Vitro Toxicology Testing Market report contains remarkable market data, present market trends, product consumption, environment, technological innovation, future prospects, upcoming technologies and the technical progress in the related industry.
The main activity of the pharmaceutical industry is quality management. Drugs must be sold as formulations that are sterile, therapeutically active, reliable, and predictable in their performance. New and improved medicinal agents are being developed at an accelerated speed. At the same time, more exact and sophisticated analytical methods are being developed for their evaluation. Due to the rising incidence of chronic diseases and the emergence of the COVID-19 pandemic, the demand for drugs and medical devices has proportionally increased. The demand for toxicology testing further gets with the increased demand for the products of the biotechnology and pharmaceutical industries.
Data Bridge Market Research analyzes that the global in-vitro toxicology testing market is expected to reach USD 27,952.36 million by 2030, at a CAGR of 12.3% during the forecast period. This market report also covers pricing analysis and technological advancements in depth.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-vitro-toxicology-testing-market&Shri
Market Definition
In-vitro toxicology testing involves testing chemicals, drugs, and other substances to assess their potential toxicity using in-vitro (non-animal) testing methods. In-vitro toxicology testing involves using cells, tissues, or cellular components outside their natural environment to evaluate substances’ safety and potential hazards. The market encompasses a wide range of in-vitro tests and assays that assess various aspects of toxicity, including but not limited to cytotoxicity, genotoxicity, carcinogenicity, organ toxicity, reproductive toxicity, and environmental toxicity. These tests are conducted on cell cultures, tissue models, or other in-vitro systems to mimic the response of biological systems to potential toxicants.
The rapidly growing pharmaceutical and medical device industry
The pharmaceutical and medical device industries have witnessed many revolutionary trends and advances, dramatically improving the medicines available to patients globally. It was possible to witness the effect of artificial intelligence and big data on the diagnosis and treatment of diseases.
Combined with their potential to remedy previously untreatable diseases, biopharmaceutical drugs’ effectiveness, and protection help pharmaceutical companies succeed. An opportunity for sustained healthy growth supports the existing biologics-development pipeline. Since 1995, the number of biotech patents applied annually has increased by 25%. More than 1,500 biomolecules are presently undergoing clinical trials, and the biologics success rate has so far been more than double that of small-molecule drugs, with 13% of biopharmaceuticals entering the phase I testing phase going on to launch.
The pharmaceutical industry relies on in-vitro toxicology testing to assess drug candidates’ safety and potential risks during the early stages of discovery and development. In-vitro testing allows researchers to evaluate the effects of substances on cells, tissues, and organs, providing valuable information on toxicity profiles, drug interactions, and potential side effects. Accurate and reliable toxicity assessments drive the demand for in-vitro toxicology testing in the pharmaceutical industry.
For instance,
- In 2022, as per the ScienceDirect article, the global medical device industry is projected to grow to about USD 615 billion in 2025 and to almost USD 800 billion in 2030, at a growing CAGR of 5.2%
- In December 2021, as per a ResearchGate article, the pharmaceutical industry was growing rapidly in Southeast Asia, which is propelling the demand for in-vitro toxicology
The prosperity and growth of these industries proportionally increase the demand for toxicity testing for the quality control of the products developed by them. Therefore, the rapidly growing pharmaceutical and medical device industries act as a driver for the growth of the market.
Market Developments
- In June 2023, Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutraceutical markets, announced it had acquired Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage technology platform for the development of ADCs. This will help the company to expand their global presence
- In May 2023, Labcorp Drug Development and BML announced the expansion of clinical laboratory testing capabilities in Japan. This will help the company to strengthen its product portfolio in this region
- In December 2022, Merck KGaA, a leading science and technology company, today announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., Cambridge, Massachusetts, USA, to discover novel antibody-drug conjugates (ADCs) leveraging Mersana’s proprietary Immunosynthen STING-agonist ADC platform, directed against up to two targets
- In October 2022, Thermo Fisher Scientific Inc. announced that it would expand its laboratory operations in Highland Heights, Kentucky, helping customers deliver life-changing medicines to patients. The current facility, which includes central lab and biomarker operations, provides biopharma customers with high-quality laboratory services to accelerate drug development. This helped the company to expand its clinical diagnostics business across various regions in the world and helped to increase the global presence in the market
- In December 2021, Aragen Life Sciences Ltd. acquired Intox Pvt.Ltd. to strengthen its safety assessment platform which has helped the company to establish its global presence
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-vitro-toxicology-testing-market?Shri
Major Players
Data Bridge Market Research recognizes the following companies as the market players in the global in-vitro toxicology testing market Thermo Fisher Scientific Inc. (U.S.), Labcorp Drug Development (U.S.), Merck KGaA (Germany), Charles River Laboratories (U.S.), Lonza (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Catalent, Inc (U.S.), SGS Société Générale de Surveillance SA (Switzerland), QIAGEN (Germany), Intertek Group plc. (U.K.), Eurofins Scientific (Luxembourg), Promega Corporation (U.S.), Aragen Life Sciences Ltd. (India), Cyprotex Plc. (U.K.), Shanghai Medicilon Inc. (China), Creative Biolabs (U.S.), BioIVT (U.S.), AAT Bioquest, Inc. (U.S.), Gentronix (UK), IONTOX (U.S.), InSphero (U.S.), MB Research Laboratories (U.S.), Creative Bioarray (U.S.), and Preferred Cell Systems (U.S.) among others.
Segment Analysis:
The global in-vitro toxicology testing market is segmented into six notable segments such as product and service, toxicology end point and test, technology, method, industry, and distribution channel.
- Based on product and service, the global in-vitro toxicology testing market is segmented into consumables, services, assays, equipments, and software
In 2023, the consumables segment is expected to dominate the global in-vitro toxicology testing market
In 2023, the consumables segment is expected to dominate the market with a market share of 34.33% and growing with a CAGR of 13.7% from 2023 to 2030. It is expected to dominate the market due to its increasing demand among the population.
- Based on toxicology end point and test, the market is segmented into ADME (absorption, distribution, metabolism, & excretion) testing, cytotoxicity testing, genotoxicity testing, dermal toxicity testing, ocular toxicity testing, organ toxicity testing, skin irritation, corrosion, & sensitization testing, phototoxicity testing, and other toxicity endpoints & tests. In 2023, the ADME (absorption, distribution, metabolism, & excretion) testing segment is expected to dominate the market with a market share of 22.01% and grow with a CAGR of 13.6% in the forecast period of 2023 to 2030
- Based on technology, the market is segmented into cell culture technologies, high-throughput technologies, molecular imaging, and OMICS technology. In 2023, the cell culture technology segment is expected to dominate the market with a market share of 35.80% and growing with a CAGR of 14.0% in the forecast period of 2023 to 2030
- Based on method, the market is segmented into cellular assays, biochemical assays, ex-vivo models, and in silico models. In 2023, the cellular assays segment is expected to dominate the market with a market share of 38.76% and growing with a CAGR of 13.8% in the forecast period of 2023 to 2030
- Based on industry, the market is segmented into pharmaceutical & biopharmaceutical companies, diagnostics, food, chemicals, and cosmetics & household products
In 2023, the pharmaceutical and biopharmaceutical companies segment is expected to dominate the global in-vitro toxicology testing market
In 2023, the pharmaceutical and biopharmaceutical companies segment is expected to dominate the market with a market share of 33.81% and grow with a CAGR of 13.7% from 2023 to 2030. It is expected to dominate the market due to the growing demand for personalized medicines and precision toxicology
- Based on distribution channel, the market is segmented into direct tender, retail sales, and others. In 2023, the direct tender segment is expected to dominate the market with a market share of 49.93% and growing with a CAGR of 13.2% in the forecast period of 2023 to 2030
Report Scope and Market Segmentation
| Report Metric | Details |
| Forecast Period | 2023 to 2030 |
| Base Year | 2022 |
| Historic Years | 2021 (Customisable to 2015-2020) |
| Quantitative Units | Revenue in USD Million, Volumes in Units, and Pricing in USD |
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Fundamental Aim of this Market Report
- Notable Market rivals around the world.
- Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
Key highlights of this Market report:
- Major restraints
- Market drivers
- Regional bifurcation
- Competitive hierarchy
- Current market tendencies
- Market concentration analysis
TOC:
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS ANALYSIS
5 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, INDUSTRY INSIGHTS
6 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, REGULATIONS
7 MARKET OVERVIEW
8 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE
9 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST
Continued…
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-vitro-toxicology-testing-market&Shri
Critical Insights Related to the adalimumab biosimilar Included in the Report:
-
- Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
- Value chain analysis of prominent players in the market
- Current trends influencing the dynamics of this market across various geographies
- Recent mergers, acquisitions, collaborations, and partnerships
- Revenue growth of this industry over the forecast period
- Marketing strategy study and growth trends
- Growth-driven factor analysis
- Emerging recess segments and region-wise market
- An empirical evaluation of the curve of this market
- Ancient, Present, and Probable scope of the market from both prospect value and volume
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Editor Details
-
Company:
- The Wire Times
